Asset Details
Do you wish to reserve the book?
Current status and future prospects of mesenchymal stem cell-derived exosomes therapy for premature ovarian insufficiency
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Current status and future prospects of mesenchymal stem cell-derived exosomes therapy for premature ovarian insufficiency
Do you wish to request the book?
Current status and future prospects of mesenchymal stem cell-derived exosomes therapy for premature ovarian insufficiency
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Current status and future prospects of mesenchymal stem cell-derived exosomes therapy for premature ovarian insufficiency
2025
Overview
Premature ovarian insufficiency (POI) is an endocrine disorder that seriously affects the reproductive health and quality of life of women of reproductive age. At present, there is no effective treatment to restore ovarian function. In recent years, accumulating studies have demonstrated that mesenchymal stem cells-derived exosomes (MSC-EXO) can restore ovarian function and fertility in POI animals by inhibiting apoptosis of ovarian granulosa cells, inflammatory response or fibrosis, and improving vascular function. However, there are still many deficiencies in this new treatment, such as the lack of standardized production of EXO, long-term safety and efficiency issues, and low homing efficiency, which limit its clinical translation and widespread application. Therefore, further research is required to address challenges such as achieving standardized mass production and targeted delivery of EXO, as well as to fully elucidate their underlying mechanisms of action. This review comprehensively summarizes the current progress of MSC-EXO in POI treatment, covering topics including MSC-EXO extraction and identification techniques, their therapeutic mechanisms in POI, POI animal models, and the clinical application potential of MSC-EXO, aiming to provide support for advancing basic research and facilitating clinical applications in this field.
Publisher
BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
Subject
/ Animals
/ Antigens
/ Architecture and energy conservation
/ Body fat
/ Costs
/ Disease
/ Enzymes
/ Exosomes
/ Female
/ Fibrosis
/ Humans
/ Lipids
/ Medicine
/ Mesenchymal Stem Cell Transplantation - methods
/ Mesenchymal Stem Cells - cytology
/ Mesenchymal Stem Cells - metabolism
/ Premature ovarian insufficiency
/ Primary Ovarian Insufficiency - therapy
/ Proteins
/ Reagents
/ Review
